In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.
MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a ...
The LDL-C reductions seen with enlicitide in both studies are in the same ballpark as those seen with injectable ...
Pharmaceutical Technology on MSN

MSD secures $700m for broad-cancer ADC asset

ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the modality.
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming patent expiry.
VIENNA--(BUSINESS WIRE)--Themis, a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer and MSD (trademark of Merck & Co ...
LOUISVILLE, KY (WAVE) - The Metropolitan Sewer District has taken 5 1/2 percent hikes every year. This year, MSD wants a 20 percent increase - the largest in almost a decade. The rate hike, which ...